secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardion Health Sciences, Inc. (—)
CIK:        0001642375
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001493152-24-022933
Event type: m_and_a
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 2.01, 5.07, 8.01, 9.01, 10.1
LLM model:  deepseek-v4-flash:cloud@v2

Guardion completes Viactiv sale for $17.2M, stockholders approve dissolution
----------------------------------------------------------------------------

- Sold Activ Nutritional (Viactiv brand) to Doctor's Best for $17.2M gross, net $16.25M cash; $225K held in escrow.
- Stockholders approved voluntary dissolution and liquidation at special meeting: 671,400 for, 41,778 against.
- Board of Directors determined dissolution is in best interests after completion of Viactiv sale; minimal operations remain.
- Pro forma shows post-sale cash ~$21.9M; ongoing revenue only from ocular products ($81K in Q1 2024).
- Company intends to liquidate and dissolve pursuant to Plan of Dissolution, subject to possible abandonment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642375/000149315224022933/0001493152-24-022933-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642375/000149315224022933/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-022933

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer